India to Guatemala: Amphotericin Export Trade Route
India has recorded 7 verified shipments of Amphotericin exported to Guatemala, representing a combined trade value of $1.2M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $168.4K USD. The leading Indian exporter is BHARAT SERUMS AND VACCINES LIMITED, which accounts for 55% of total export value with 2 shipments worth $653.3K USD. On the buying side, SOLMEDICA S.A. is the largest importer in Guatemala with $653.3K USD in purchases. The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, REMUS PHARMACEUTICALS PVT LTD, S R S PHARMACEUTICALS PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Guatemala Amphotericin corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $1.2M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's amphotericin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $168.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 21.9%, placing it at rank #2 among India's top amphotericin export destinations globally.
On the import side, key buyers of Indian amphotericin in Guatemala include SOLMEDICA S.A., ARAEL DE CENTROAMERICA SA, AVIV FARMACEUTICA SACALZADA ATANASIO TZUL and 1 others. SOLMEDICA S.A. is the single largest importer with 2 shipments valued at $653.3K USD.
